Health ❯ Healthcare ❯ Biotechnology

Clinical Trials

Drug Development Duchenne Muscular Dystrophy Cancer Research Gene Therapy Immunotherapy Cancer Therapy Frontotemporal Dementia Alzheimer's Disease Antisense Oligonucleotides Autoimmune Diseases Rare Diseases Metabolic Diseases AI in Medicine Pulmonary Sarcoidosis

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

Failure to convert higher progranulin levels into slowed FTD progression is prompting a shift of resources to other trials.